Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Methods in Molecular Biology (Clifton, N.J.)|June 28, 2012
Engineering and expression of bibody and tribody constructs in mammalian cells and in the yeast Pichia pastorisSteve SchoonoogheMethods in Molecular Biology (Clifton, N.J.)|August 22, 2012
Production of antibody derivatives in the methylotrophic yeast Pichia pastorisSteve Schoonooghe, Jannick Leoen, Jurgen HaustraeteJournal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 26, 2003
Optimizing expression and purification from cell culture medium of trispecific recombinant antibody derivativesAn Willems, Jannick Leoen, Steve Schoonooghe, et al.Protein Engineering, Design & Selection : PEDS|July 10, 2010
PH1-derived bivalent bibodies and trivalent tribodies bind differentially to shed and tumour cell-associated MUC1Steve Schoonooghe, Ingrid Burvenich, Liesbet Vervoort, et al.Cancer Immunology, Immunotherapy : CII|May 14, 2005
CD3 x CD28 cross-interacting bispecific antibodies improve tumor cell dependent T-cell activationAn Willems, Steve Schoonooghe, Dominique Eeckhout, et al.EJNMMI Research|April 6, 2013
Generation and in vivo characterization of a chimeric αvβ5-targeting antibody 14C5 and its derivativesCaroline Dumolyn, Steve Schoonooghe, Lieselotte Moerman, et al.BMC Biotechnology|August 13, 2009
Efficient production of human bivalent and trivalent anti-MUC1 Fab-scFv antibodies in Pichia pastorisSteve Schoonooghe, Vladimir Kaigorodov, Monika Zawisza, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2005
In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma modelIngrid Burvenich, Steve Schoonooghe, Bart Cornelissen, et al.Immunobiology|August 14, 2012
Novel applications of nanobodies for in vivo bio-imaging of inflamed tissues in inflammatory diseases and cancerSteve Schoonooghe, Damya Laoui, Jo A Van Ginderachter, et al.Immunobiology|November 28, 2016
Structural evaluation of a nanobody targeting complement receptor Vsig4 and its cross reactivityYurong Wen, Zhenlin Ouyang, Steve Schoonooghe, et al.Pageof 4